Si prevede che il mercato globale del controllo delle nascite pretermine raggiungerà i 1.809,0 milioni di dollari nel 2025 rispetto ai 1.190,5 milioni di dollari del 2017. Si stima che il mercato crescerà con un CAGR del 4,9% nel periodo 2018-2025.
Il Nord America è il mercato geografico più grande e si prevede che sarà il maggiore generatore di entrate durante il periodo di previsione, mentre si prevede che il mercato assisterà a una crescita a un ritmo significativo nella regione Asia Pacifico (APAC) durante il periodo di previsione. Si prevede che il mercato dei contraccettivi a termine nell'Asia del Pacifico crescerà con un CAGR del 5,1% raggiungendo i 325,6 milioni di dollari nel 2025 rispetto ai 222,4 milioni di dollari del 2017.
Mercati regionali redditizi
Market Insights
Numero crescente di nascite premature
C'è stato un aumento graduale del numero di nascite premature negli ultimi anni. Secondo l’Organizzazione Mondiale della Sanità (OMS), la nascita prematura è una delle principali cause di morte tra i bambini di età inferiore a 5 anni. Potrebbe essere dovuto all'induzione precoce del travaglio o al parto cesareo. Gravidanze multiple, infezioni e condizioni croniche come il diabete e l'ipertensione sono altre cause comuni di nascite premature. Secondo i Centri per il controllo e la prevenzione delle malattie (CDC), è stata osservata una riduzione delle nascite premature nel periodo 2007-2014. Nel 2015, il basso peso alla nascita e le nascite premature hanno rappresentato circa il 17% delle morti infantili. Tuttavia, il numero è aumentato nel corso del 2016, con differenze razziali ed etniche. Negli Stati Uniti, 1 bambino su 10 nato è nato pretermine.
Iniziative per la prevenzione delle nascite pretermine
Un certo numero di organizzazioni governative e non governative sono impegnate ad aumentare la consapevolezza sulla nascita pretermine in vari paesi attraverso il globo. Organizzazioni come CDC hanno implementato strategie per ridurre le nascite premature. Queste strategie includono la fornitura di servizi sanitari prima e tra le gravidanze; determinare la popolazione a rischio di parto pretermine e fornire un trattamento immediato, scoraggiando i parti prima delle 39 settimane senza necessità medica; e prevenire gravidanze indesiderate attendendo almeno 18 mesi tra una gravidanza e l'altra.
Quadro normativo rigoroso
Autorità di regolamentazione come Food & La Drug Administration (FDA), l'Agenzia europea per i medicinali (EMA) e altri hanno costantemente mostrato una posizione dura nei confronti dei produttori di biotecnologie per contenitori farmaceutici. Gli operatori del mercato devono rispettare i requisiti e le linee guida della FDA e di altre autorità di regolamentazione e dovrebbero tenere costantemente sotto controllo le modifiche apportate di tanto in tanto a queste linee guida. I produttori di farmaci e dispositivi medici devono rispettare queste normative relative alle attuali buone pratiche di produzione (cGMP) e alle buone pratiche di laboratorio (GLP) al fine di garantire una corretta progettazione, monitoraggio e controllo dei processi e delle strutture di produzione. Inoltre, qualsiasi deviazione dai protocolli registrati, dalle richieste e dai requisiti di queste linee guida porta alla cessazione degli studi clinici intrapresi dalle aziende farmaceutiche.
Inoltre, la FDA richiede anche un forte monitoraggio della sicurezza e un rigoroso piano di distribuzione che il produttore deve seguire. La non conformità da parte dei produttori influisce sulle vendite dei prodotti sul mercato e può portare al ritiro dei prodotti commercializzati a causa di casi registrati per deficit delle promesse nella funzione e nelle prestazioni del prodotto o terapeutico può offuscare la reputazione dell'azienda rischiando la sua crescita futura. In caso di studi clinici per lo sviluppo di terapie per il controllo delle nascite pretermine, la FDA e altri organismi di regolamentazione hanno norme rigorose a causa delle quali è difficile per i produttori riunire pazienti in gravidanza, generando mancanza di modelli funzionanti. Ciò a sua volta si traduce nel rifiuto delle sperimentazioni e può quindi fungere da ostacolo alla crescita del mercato.
Approfondimenti sul prodotto
Il mercato del controllo delle nascite pretermine in base al metodo di trattamento è segmentato in trattamenti e dispositivi farmaceutici. Il segmento dei trattamenti farmaceutici è destinato a crescere con una quota di mercato maggiore del 55,6% nel 2017. Si prevede che il mercato dei trattamenti farmaceutici aumenterà durante il periodo di previsione dal 2017 al 2025, a un ritmo significativo.
  ;Mercato del controllo delle nascite pretermine, per metodo di trattamento
Approfondimenti strategici
Le collaborazioni/acquisizioni sono state osservate come la strategia più adottata nel mercato globale dei controlli delle nascite pretermine industria del controllo delle nascite. Di seguito sono elencati alcuni dei lanci di prodotti e degli accordi stipulati dagli attori del mercato;
2018: CooperSurgical aveva acquisito le attività di The LifeGlobal Group e delle sue affiliate. Il Gruppo LifeGlobal è un fornitore leader a livello mondiale di dispositivi per la fecondazione in vitro.
CONTROLLO DELLE NASCITE PRE-TERMINE: SEGMENTAZIONE DEL MERCATO
Per metodo di trattamento
- Dispositivi
- Cerclaggio cervicale
- Pessari vaginali
- Trattamento farmaceutico
Per geografia
- Nord America
- Stati Uniti
- Canada
- Messico
- Europa
- Francia
- Germania
- Regno Unito
- Asia Pacifico
- Giappone
- Cina
- India < /ul>
- Medio Oriente e Medio Oriente Africa
- Emirati Arabi Uniti
- Arabia Saudita
- Sudafrica
- Sud e Africa America Centrale
- Argentina
- Brasile
Profili aziendali
- Cooper Surgical
- Medgyn Products
- Integra Life sciences Corporation
- Panpac Medical Corp.
- Dr. Arabin GMBH & Co. KG
- Amag Pharmaceuticals
- Ben Way Enterprises Sdn Bhd
- Personal Medical Corp.
- Bioteque America Inc.
- Bliss Gvs Pharma Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
- CooperSurgical, Inc.
- MEDGYN PRODUCTS, INC.
- Integra LifeSciences Corporation
- Panpac Medical Corp.
- Personal Medical Corp
- Bioteque America, Inc.
- Bliss GVS Pharma Ltd.
- Dr. Arabin GmbH & Co. KG
- AMAG Pharmaceuticals
- BEN WAY ENTERPRISES SDN BHD
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2018
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2018
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2018
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)